Furthermore, CD40 expression on tumor cells correlated with a longer overall survival (OS), suggesting that the interaction between tumor cells and CD40L+ CD4+ T cells could stimulate antigen presentation and lymphoma-specific T-cell responses [31]. The gene discussed is CD40LG; the disease is neoplasm.